PRESENZE ED INFLUENZE CATALANE NELL'ARCHITETTURA NAPOLETANA DEL REGNO D'ARAGONA (1442-1503)VENDITTI A.NAPOLI NOBILISSIMA. 1974, Vol 13, Num 1, pp 3-21Article

UN'OPERA DEL RAGUZZINI: IL PALAZZO TERRAGNOLI A BENEVENTOVENDITTI A.STUDI STOR. ARTE V. MARIANI. 1971, Vol P. VOL, pp 215-226Article

NOTE SU ANTONIO CANEVARI ARCHITETTO NOTES SUR A. CANEVARI, ARCHITECTEVENDITTI A.STUDI ROMANI. 1973, Vol 21, Num 3, pp 358-365Article

PRESENZE BIZANTINE NELL'ARCHITETTURA DI PUGLIAVENDITTI A.1970, 105 p.Book

Le chiese bizantine di CapriVENDITTI A.Byzantino-Sicula II (Mél. G. Rossi-Taibbi). 1975, Vol p. vol, pp 513-530Article

PROBLEMI DI LETTURA E DI INTERPRETAZIONE DELL'ARCHITETTURA PALEOCRISTIANA DI NAPOLIVENDITTI A.NAPOLI NOBILISSIMA. 1973, Vol 12, Num 5, pp 177-188Article

THE LOGGIA DEL CAPITANIATO. NOTE ON THE PICTORIAL DECORATION BY FRANCO BARBIERIVENDITTI A.1971, 84 p.Book

Testimonianze brunelleschiane a Napoli e in Campania in Filippo Brunelleschi. La sua opera e il suo tempo. Vol. 2VENDITTI, A.Congrès. 1980, pp 753-777Conference Proceedings

Endogenous cycles in discrete symmetric multisector optimal growth modelsCARTIGNY, P; VENDITTI, A.Journal of optimization theory and applications. 1995, Vol 86, Num 1, pp 17-36, issn 0022-3239Article

Endogenous fluctuations in two-sector models : Role of preferencesNISHIMURA, K; TAKAHASHI, H; VENDITTI, A et al.Journal of optimization theory and applications. 2006, Vol 128, Num 2, pp 309-331, issn 0022-3239, 23 p.Article

Role of human leukocyte interferon-α in the treatment of patients with polycythemia veraSTASI, R; VENDITTI, A; DEL POETA, G et al.The American journal of the medical sciences. 1998, Vol 315, Num 4, pp 237-241, issn 0002-9629Article

All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemiaVENDITTI, A; STASI, R; SIMONE, M. D et al.Leukemia. 1995, Vol 9, Num 7, pp 1121-1125, issn 0887-6924Article

Serum IL-13 concentration response to surgical treatment in patients with laryngeal squamous cell carcinomaPIGNATARO, L; ARISI, E; VENDITTI, A et al.The International journal of biological markers. 2003, Vol 18, Num 4, pp 311-313, issn 0393-6155, 3 p.Article

Acute megakaryoblastic leukemia: experience of GIMEMA trialsPAGANO, L; PULSONI, A; SPECCHIA, G et al.Leukemia. 2002, Vol 16, Num 9, pp 1622-1626, issn 0887-6924Article

Enumeration of CD34⁺ hematopoietic progenitor cells for clinical transplantation : Comparison of three different methodsVENDITTI, A; BATTAGLIA, A; SANTINELLI, S et al.Bone marrow transplantation (Basingstoke). 1999, Vol 24, Num 9, pp 1019-1027, issn 0268-3369Article

Minimally differentiated acute myeloid leukemia (AML-M0) : Comparison of 25 cases with other French-American-British subtypesVENDITTI, A; DEL POETA, G; SIMONE, M. D et al.Blood. 1997, Vol 89, Num 2, pp 621-629, issn 0006-4971Article

High-dose chemotherapy in adult acute myeloid leukemia : Rationale and resultsSTASI, R; VENDITTI, A; DEL POETA, G et al.Leukemia research. 1996, Vol 20, Num 7, pp 535-549, issn 0145-2126Article

ALL-TRANS Retinoic acid plus low doses of cytarabine for the treatment of poor-risk acute myeloid leukemiasVENDITTI, A; STASI, R; PAPA, G et al.Annals of hematology (Print). 1993, Vol 66, Num 2, pp 59-60, issn 0939-5555Conference Paper

High interleukin-6 plasma levels in acute promyelocytic leukemiaSTASI, R; VENDITTI, A; DEL POETA, G et al.Annals of hematology (Print). 1992, Vol 64, Num 6, pp 303-304, issn 0939-5555Article

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantationVENDITTI, A; MAURILLO, L; PICARDI, A et al.Leukemia. 2003, Vol 17, Num 11, pp 2178-2182, issn 0887-6924, 5 p.Article

Nanomolar level of resveratrol (trans-3,5,4'-trihydroxystilbene) is required, but is not sufficient, to inhibit the growth of human monocytoid tumor cells through an apoptotic-like mechanismCORSI, M. M; PONTI, W; FERRARA, F et al.Drugs under experimental and clinical research. 2002, Vol 28, Num 6, pp 235-242, issn 0378-6501, 8 p.Article

A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromesVENDITTI, A; TAMBURINI, A; AMADORI, S et al.Annals of hematology (Print). 2000, Vol 79, Num 3, pp 138-142, issn 0939-5555Article

Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemiaVENDITTI, A; DEL POETA, G; FORTE, L et al.Leukemia. 1998, Vol 12, Num 7, pp 1056-1063, issn 0887-6924Article

Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia : Analysis of prognostic factorsSTASI, R; VENDITTI, A; DEL POETA, G et al.Cancer. 1996, Vol 77, Num 12, pp 2476-2488, issn 0008-543XArticle

Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniquesSTASI, R; DEL POETA, G; VENDITTI, A et al.Hematologic pathology. 1995, Vol 9, Num 2, pp 79-94, issn 0886-0238Article